Prognostic value of pleural effusion, CA-125 and NT-proBNP in patients with acute decompensated heart failure

被引:1
作者
Davutoglu, Vedat [1 ]
Yildirim, Cuma [2 ]
Kucukaslan, Hasan [2 ]
Yuce, Murat
Sari, Ibrahim
Tarakcioglu, Mehmet [3 ]
Akcay, Murat
Cakici, Musa
Ceylan, Nurdan [3 ]
Al, Behcet [2 ]
机构
[1] Gaziantep Univ, Sch Med, Dept Cardiol, TR-27310 Gaziantep, Turkey
[2] Gaziantep Univ, Dept Emergency Med, TR-27310 Gaziantep, Turkey
[3] Gaziantep Univ, Dept Biochem, TR-27310 Gaziantep, Turkey
关键词
decompensated heart failure; pleural effusion; CA-125; NT-proBNP; prognosis; CARBOHYDRATE ANTIGEN-125; SERUM-LEVELS; SEVERITY; INTERLEUKIN-6; PROGRESSION; CA125;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Acute decompensated heart failure (HF) is a serious complication associated with significant morbidity and mortality. The CA-125 and NT-proBNP levels have been shown in some studies to predict the outcome, however, the prognostic value of other simple clinical parameters such as pleural effusion has not been established yet. Aim: To assess the prognostic value of pleural effusion regarding in-hospital and 6-month follow-up outcome in patients with acute decompensated HF and the relationship between pleural effusion and CA-125 and NT-proBNP levels. Methods and results: The CA-125 and NT-proBNP levels were measured at baseline and the presence of pleural effusion was examined on chest radiograms. One hundred patients were prospectively followed until the occurrence of cardiac death, defined as death from worsening HF or sudden cardiac death, or completion of follow-up period. There were 27 deaths over the course of 6 months of follow-up. An insignificant trend towards higher values of CA-125 was found in patients with pleural effusion. Univariate Cox regression analysis showed that there was no relationship between pleural effusion and in-hospital outcome as well as mortality during 6-month follow-up. The CA-125 and NT-proBNP levels predicted mortality. Multivariate Cox regression analysis showed that only CA-125 was an independent predictor of the 6-month outcome (RR: 1.2; 1.04-1.4; p = 0.001). Conclusions: In patients with acute decompensated HF, accompanying pleural effusion did not predict mortality or rehospitalisation during the 6-month follow-up. The increased CA-125 level was found to be an independent predictor of poor outcome, irrespective of pleural effusion.
引用
收藏
页码:771 / 778
页数:8
相关论文
共 25 条
[1]   A survey on the quality of care among patients with heart failure in Europe [J].
Cleland, JGF ;
Swedberg, K ;
Cohen-Solal, A ;
Cosin-Aguilar, J ;
Dietz, R ;
Follath, F ;
Gavazzi, A ;
Hobbs, R ;
Korewicki, J ;
Madeira, HC ;
Preda, I ;
van Gilst, WH ;
Widimsky, J ;
Mareev, V ;
Mason, J ;
Freemantle, N ;
Eastaugh, J .
EUROPEAN JOURNAL OF HEART FAILURE, 2000, 2 (02) :123-132
[2]   Is the prognosis of heart failure improving? [J].
Cleland, JGF ;
Gemmell, I ;
Khand, A ;
Boddy, A .
EUROPEAN JOURNAL OF HEART FAILURE, 1999, 1 (03) :229-241
[3]   Serum levels of carbohydrate antigen 125 in patients with chronic heart failure - Relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis [J].
D'Aloia, A ;
Faggiano, P ;
Aurigemma, G ;
Bontempi, L ;
Ruggeri, G ;
Metra, M ;
Nodari, S ;
Dei Cas, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (10) :1805-1811
[4]  
Davutoglu V, 2005, J HEART VALVE DIS, V14, P251
[5]   Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure - A clinical review [J].
de Virginy, David R. Buvat .
HEART FAILURE REVIEWS, 2006, 11 (04) :333-344
[6]   Elevated serum CA 125 levels in mitral stenotic patients with heart failure [J].
Duman, C ;
Ercan, E ;
Tengiz, I ;
Bozdemir, H ;
Ercan, HE ;
Nalbantgil, I .
CARDIOLOGY, 2003, 100 (01) :7-10
[7]   Clinical management of the patient with pleural effusion [J].
Ferrer, J ;
Roldán, J .
EUROPEAN JOURNAL OF RADIOLOGY, 2000, 34 (02) :76-86
[8]   Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure [J].
Gwechenberger, M ;
Hülsmann, M ;
Berger, R ;
Graf, S ;
Springer, C ;
Stanek, B ;
Pacher, R .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (07) :839-844
[9]   Do cytokines enable risk stratification to be improved in NYHA functional class III patients?: Comparison with other potential predictors of prognosis [J].
Kell, R ;
Haunstetter, A ;
Dengler, TJ ;
Zugck, C ;
Kübler, W ;
Haass, M .
EUROPEAN HEART JOURNAL, 2002, 23 (01) :70-78
[10]   Relationship between cytokines and tumour markers in patients with chronic heart failure [J].
Kosar, F ;
Aksoy, Y ;
Ozguntekin, G ;
Ozerol, I ;
Varol, E .
EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (03) :270-274